Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label, nonrandomized extension to study AC-066A301. The study will assess
safety and tolerability of ACT-385781A while providing a means for continuing treatment after
ending participation in study AC-066A301.